Is Steroid-Induced Osteoporosis Preventable?
- 17 June 1993
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 328 (24) , 1781-1782
- https://doi.org/10.1056/nejm199306173282411
Abstract
Osteoporosis is the most serious side effect of long-term corticosteroid therapy. The bone mass in corticosteroid-treated patients is reduced in the forearm, spine, and proximal femur, with more loss in trabecular than in cortical bone. The bone mass lost varies from 10 to 40 percent, depending on the site examined, the dose and duration of corticosteroid therapy, the particular corticosteroid used, and the disease treated. The tendency of corticosteroids to damage trabecular bone more than cortical bone is reflected in the greater loss of lumbar mineral density assessed in the lateral projection than in the anteroposterior projection1. More important, . . .Keywords
This publication has 8 references indexed in Scilit:
- Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and CalcitoninNew England Journal of Medicine, 1993
- Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric studyOsteoporosis International, 1993
- Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone lossJournal of Bone and Mineral Research, 1992
- Constitutive enzymes of matrix vesiclesBone and Mineral, 1992
- Is there an effective treatment for glucocorticoid-induced osteoporosis?Calcified Tissue International, 1991
- PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)The Lancet, 1988
- Effect of oral 1,25‐dihydroxyvitamin D and calcium on glucocorticoid‐induced osteopenia in patients with rheumatic diseasesArthritis & Rheumatism, 1984
- Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.Journal of Clinical Investigation, 1979